Recently, the European Journal of Breast Health published an international study conducted by the SIS members on breast cancer management during COVID-19 pandemic woldwide. This study found that :
- Breast cancer diagnosis and treatment were deeply impacted since the beginning of the SARS-CoV-2 pandemic.
- In the light of recent findings on COVID-19 risk among women with breast cancer, most of these changes should not be maintained as the risk of severe COVID-19 is related to comorbidities and age rather than breast cancer.
- Only women with breast cancer aged over 65 or with comorbidities require adaptation of their cancer management, according to the Senologic International Society.